title: Complications of using OKT3 for induction of immunosuppression in recipients of kidneys from nonheart beating donors.
authors.affiliation: Department of Surgery, Leicester General Hospital, United Kingdom.
authors.forename: E O
authors.initials: EO
authors.lastname: Kehinde
authors.forename: P S
authors.initials: PS
authors.lastname: Veitch
authors.forename: S D
authors.initials: SD
authors.lastname: Scriven
authors.forename: K
authors.initials: K
authors.lastname: Varty
authors.forename: J D
authors.initials: JD
authors.lastname: Morgan
authors.forename: P
authors.initials: P
authors.lastname: Furness
authors.forename: T
authors.initials: T
authors.lastname: Horsburgh
authors.forename: J
authors.initials: J
authors.lastname: Feehally
authors.forename: P R
authors.initials: PR
authors.lastname: Bell
mesh_terms: D000328:Adult; D000368:Aged; D001706:Biopsy; D004334:Drug Administration Schedule; D006323:Heart Arrest; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D007684:Kidney Tubules / Q000473:pathology; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000009:adverse effects / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use; D014019:Tissue Donors
chemical_list: D016853:Muromonab-CD3; D011239:Prednisolone